Skip to main content

Table 2 Results of multiple cox regression

From: Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy

Subgroup

Patients, No.

OS

PFS

HR (95% CI)

P

HR (95% CI)

P

TNM stage

     

 II

65

Reference

 

Reference

 

 III

42

1.48 (1.04–2.47)

0.13

1.42 (1.06–2.34)

0.17

 IV

19

2.10 (1.09–4.04)

< 0.05

1.98 (1.02–3.84)

< 0.05

S2

  

< 0.001

 

< 0.05

 Over-expression

79

Reference

 

Reference

 

 Under-expression

47

2.26 (1.40–3.67)

 

2.23 (1.36–3.65)

 

S3

  

< 0.05

 

< 0.05

 Over-expression

92

Reference

 

Reference

 

 Under-expression

34

0.48 (0.29–0.79)

 

0.55 (0.33–0.90)

 
  1. Overall survival (OS), progression-free survival (PFS), hazard ratio (HR).